DNA/RNA

Description
Expression
In platelets; upregulated during granulocyte differentiation (see below); also expressed in thy-mus, spleen, kidney, intestine, cochlea.
Function
Binds actin; protein of the cytoskeleton; role in cell shape and motility, and in cell division.
Mutations
Germinal
In autosomal dominant giant-platelet disorders.
Somatic
In non Hodgkin lymphomas.
Implicated in
Disease
The autosomal dominant giant-platelet disorders, MayHegglin anomaly (MHA), Fechtner syndrome (FTNS), and Sebastian syndrome (SBS), which share a triad of thrombocytopenia, large platelets (macrothrombocytopenia (MTCP)) and characteri-stic leukocyte inclusions (Dohle-like bodies), Epstein syndrome, which associates additional Alport-like clinical features (inherited sensorineural deafness, cataracts, nephritis), and MTCP without leukocyte inclusions, as well as a nonsyndromic hereditary hearing impairment are all caused by (germinal) mutations in MYH9. These disorders appear to represent a class of allelic disorders with variable phenotypic diversity. No clear no geno-type-phenotype correlation was identified.
Anaplasic large cell lymphoma (ALCL) with t(2;22)(p23;q12) --> ALK-CLTC Disease ALCL are high grade non Hodgkin lymphomas; ALK+ ALCL are ALCL where ALK is involved in a fusion gene; ALK+ ALCL represent 50 to 60 % of ALCL cases (they are CD30+, ALK+); belong to the "cytoplasmic ALK+" subset.
